Decrease in Glycemic Index Associated with Improved Glycemic Control among Latinos with Type 2 Diabetes
Monica L Wang, Lauren Gellar, Brian H Nathanson, Lori Pbert, Yunsheng Ma, Ira Ockene, Milagros C Rosal, Monica L Wang, Lauren Gellar, Brian H Nathanson, Lori Pbert, Yunsheng Ma, Ira Ockene, Milagros C Rosal
Abstract
Background: Glycemic index and glycemic load are used to facilitate glucose control among adults with type 2 diabetes, with a low glycemic index diet associated with improved glycemic control.
Objective: To examine long-term longitudinal associations between changes in glycemic index and glycemic load with glycemic and metabolic control among Latino adults with diabetes.
Design: Secondary data from intervention and comparison participants in the Latinos en Control trial (2006 to 2008) were analyzed.
Participants/setting: Data on dietary intake and metabolic characteristics were from low-income, Latino adults (N=238; 87.7% Puerto Rican) with type 2 diabetes.
Intervention: The Latinos en Control trial was a randomized clinical trial targeting diabetes self-management among Latinos with type 2 diabetes. Participants were randomized to a group-based behavioral intervention or usual care and followed through 12 months.
Main outcome measures: Outcomes included hemoglobin A1c (HbA1c) levels, fasting blood glucose, lipid profiles, anthropometrics, and blood pressure.
Statistical analysis: Glycemic index and load were analyzed using data from three 24-hour dietary recalls conducted at baseline, 4 months, and 12 months. Repeated measures regression models were used to examine change in glycemic index and load associated with metabolic characteristics at 12 months. Covariates included sex, age, body mass index, blood pressure, total energy intake, medication use and intensity, physical activity, intervention status (intervention vs usual care), and time.
Results: Increases in glycemic index from baseline to 12 months were associated with increased logarithm of HbA1c levels (β=0.003; P=0.034) and waist circumference (β=0.12; P=0.026) over time, but not with fasting glucose, blood lipids, or body mass index. There was modest evidence to support small, positive associations between glycemic load and HbA1c levels and waist circumference.
Conclusions: Lowering glycemic index is associated with improvements in certain metabolic risk factors among Latinos with diabetes. Targeting glycemic index may be an important component of dietary strategies for diabetes self-management.
Trial registration: ClinicalTrials.gov NCT00848315.
Keywords: Glycemic index; Glycemic load; Latinos; Metabolic risk factors; Type 2 diabetes.
Conflict of interest statement
Conflict of Interest Statement
The authors have no conflicts of interest to disclose.
Copyright © 2015 Academy of Nutrition and Dietetics. Published by Elsevier Inc. All rights reserved.
Figures

Source: PubMed
Upcoming Clinical Trials
-
Fred Hutchinson Cancer CenterPromiCell Therapeutics, Inc.Not yet recruitingStage IVB Prostate Cancer AJCC v8 | Metastatic Castration-Resistant Prostate AdenocarcinomaUnited States
-
Arizona State UniversityNot yet recruitingExercise | Blood Pressure | Nutrition KnowledgeUnited States
-
Oregon Health and Science UniversityInSightecNot yet recruiting
-
Tongji HospitalNot yet recruiting
-
Sakarya UniversityNot yet recruitingPeripheral Artery Disease | Atherectomy in Diseased Lower Extremity ArteriesTurkey (Türkiye)
-
Ziauddin UniversityNot yet recruitingSacroiliac Joint Dysfunction
-
Eli Lilly and CompanyNot yet recruitingObesity | Diabetes Mellitus, Type 1 | OverweightUnited States
-
Cairo UniversityNot yet recruitingDental Caries | Cervical Caries
-
IRCCS San RaffaeleNot yet recruitingPancreatic Neoplasms | Radiomics | Pancreatic Ductal Adenocarcinoma (PDAC) | Endoscopic Ultrasound (EUS) | Artificial Intelligence (AI)Italy
-
MediLink Therapeutics (Suzhou) Co., Ltd.Not yet recruitingMetastatic Pancreatic Cancer | Pancreatic Ductal Adenocarcinoma (PDAC)China
-
National University of Modern LanguagesNot yet recruitingBody Dysmorhpic Disorder | Positive Psychology
-
Shanghai Minwei Biotechnology Co., LtdRecruitingType 2 Diabetes Mellitus (T2DM) | MASH - Metabolic Dysfunction-Associated Steatohepatitis | Overweight , ObesityChina